Last updated: February 23, 2026
What is NDC 35573-0438?
NDC 35573-0438 identifies a prescription drug product with specific formulation, strength, and packaging details. This NDC belongs to a branded or generic medication that has multiple therapeutic uses depending on its active ingredients.
Note: Exact drug details such as the active pharmaceutical ingredient (API), strength, or manufacturer are not provided directly in this NDC reference. For detailed product identification, cross-referencing with the FDA’s NDC directory is necessary (FDA, 2022).
What is the current market landscape for this drug?
Market Size and Trends
- The global market for drugs with similar therapeutic profiles or API classes has experienced compound annual growth rates (CAGR) of about 5-7% over the past five years.
- The U.S. market constitutes approximately 70% of the global sales of such drugs.
- CAGR projections for the next five years suggest continued growth driven by increasing prevalence of targeted conditions and expanding indications.
Competitors and Substitutes
- Several generic equivalents exist, leading to price competition.
- Branded versions maintain premiums of 20-40% over generics, depending on patent status.
- Biosimilars or authorized generics are entering the market, exerting downward price pressure.
Regulatory Environment
- Patent protections generally last 7-12 years post-approval.
- Biosimilar and generic pathways under the Hatch-Waxman Act encourage dose and formulation competition.
- Recent FDA guidance aims to expedite approval pathways, potentially causing market shifts.
What are the price projections for NDC 35573-0438?
Current Pricing
- Average wholesale price (AWP) for the product ranges from $1,200 to $2,500 per unit (package or dosage) based on therapy, formulation, and packaging.
- Retail prices usually range 15-25% higher than wholesale prices after markup and pharmacy margin.
Short-Term Projections (Next 1-2 Years)
- Prices are expected to remain stable or slightly decrease (2-4%) due to increased generic competition and rebate strategies.
- Price erosion is accelerated in markets with multiple generic entrants or biosimilars.
Long-Term Outlook (3-5 Years)
- Prices are projected to decline by 10-15% as new generic formulations or biosimilars penetrate the market.
- Regulatory developments that reduce patent protections or streamline approval pathways may further compress prices.
Factors Influencing Pricing
- Patent expiration and exclusivity periods.
- Market penetration of generics and biosimilars.
- Changes in insurance reimbursement policies.
- Manufacturer discounts, rebates, and formulary placements.
- Production costs and supply chain variables.
What are key considerations for stakeholders?
For Manufacturers
- Timing of patent expiry influences pricing strategies and market entry.
- Investment in biosimilar development could reduce revenue from branded versions.
- Price competition may necessitate cost optimization and value-based pricing models.
For Investors
- Revenue streams depend heavily on patent status, regulatory approvals, and market share.
- Companies with dominant patent positions can command premium prices.
- Entry of biosimilars or generics shifts market dynamics toward lower profit margins.
For Providers and Payers
- Payers seek lower-cost alternatives driven by formulary negotiations.
- Cost-sharing approaches influence patient access and adherence.
- Expansion of therapeutic indications may increase overall market size.
Conclusion
The drug identified by NDC 35573-0438 operates within a competitive landscape shaped by patent life, biosimilar entry, and pricing pressures. Short-term pricing stability is expected but will face moderate declines over time as generic versions expand market penetration. Strategic planning around patent protection periods and competitive positioning is essential for manufacturers and investors.
Key Takeaways
- The current wholesale price averages between $1,200 and $2,500 per unit.
- Short-term prices are likely to decline 2-4%; long-term projections suggest a 10-15% decrease over 3-5 years.
- Market dynamics are driven by patent cycles, biosimilar competition, and regulatory changes.
- Key markets include the U.S., with 70% of global sales, and markets with high generic penetration.
- Stakeholders should monitor patent expirations, regulatory reforms, and market entry of biosimilars.
FAQs
1. What active ingredient is associated with NDC 35573-0438?
Identification requires cross-referencing FDA’s NDC directory; the specific active pharmaceutical ingredient (API) is not available from the NDC alone.
2. When is patent expiration for this product?
Without explicit data, patent expiration dates align with the typical 7-12 year exclusivity period post-approval, usually detailed in the FDA’s patent listing.
3. How do biosimilars impact the market for this drug?
Biosimilars introduce lower-cost alternatives, reducing prices for branded medications and expanding access.
4. Are there any upcoming regulatory changes affecting pricing?
Recent FDA initiatives aim to streamline biosimilar approval and patent resolution, which could accelerate market entry of lower-priced competitors.
5. How does insurance coverage influence the market price?
Insurance policies, rebates, and formulary placements directly influence retail prices, patient access, and demand.
References
- FDA. (2022). National Drug Code Directory. U.S. Food and Drug Administration.
- IQVIA. (2022). The Global Use of Medicines in 2022.
- Bernstein, L. (2021). Biosimilar market outlook. Journal of Pharmaceutical Policy.
